1 min read

ICPM 2022

20th International Conference on Pharmaceutical Medicine, 19-21st October 2022

 

SFL, a Veristat company,  will participate in a Round table at the 20th International Conference on Pharmaceutical Medicine, at the  Stavros Niarchos Foundation Cultural Center, Athens:

 

We are pleased to announce that Shayesteh Fürst-Ladani, will speak about “How much clinical data from medical device studies is enough to support application for CE Certification? ” in the Roundtable organized from 9:00-10:30 am.

Don’t miss Shayesteh and the full line-up of experts convening to discuss the very latest clinical and regulatory updates.

 

Chair: Ghazaleh Gouya, Priv. Doz Dr. med Cardiologist, Founder of Gouya insights, GPMed Board Member & IFAPP Board Member

Speakers:

‘Design of clinical MD investigations and approvable endpoints’

Dr. Andreas Beust, Chief Scientific Officer, GCP-Service International Ltd. & Co. KG

 

‘ How much clinical data from Medical Device studies is enough for CE mark?"

Shayesteh Fürst-Ladani, MBA, MSc, GFMD, Senior Vice President SFL, Head of SFL Group

 

‘Guidance documents"

Tom Melvin, Associate Professor of Medical Device Regulatory Affairs, School of Medicine, Trinity College

 

Veristat and SFL, a Veristat company,  offer solutions for Pharma and MedTech industry.  Featured solutions include strategic and operational support from early development to regulatory approval, market access, quality assurance, pharmacovigilance, and supply chain management, as well as clinical development services including global clinical operations, biostatistics and programming.

 

 

Schedule A Meeting

If you would like to meet us at the 20th International Conference on Pharmaceutical 2022, feel free to contact us to arrange a meeting through the form. 

 

 

Social Media_Event_ICPM 2022

 

Conference Details

Website: https://www.icpm2022.gr/

 

 

Share This Event:

   

1 min read

Chief Medical Officer Summit -CMO 360°

Meet the Veristat team at Booth #3, April 17th and 18th in Boston

The Science-First CRO™ and Consultancy Ready to...

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...